161 related articles for article (PubMed ID: 32916389)
41. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
[TBL] [Abstract][Full Text] [Related]
42. A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
Dorjsuren D; Eastman RT; Song MJ; Yasgar A; Chen Y; Bharti K; Zakharov AV; Jadhav A; Ferrer M; Shi PY; Simeonov A
PLoS One; 2022; 17(1):e0261821. PubMed ID: 35041689
[TBL] [Abstract][Full Text] [Related]
43. Anti-Zika Activity of a Library of Synthetic Carbohydrate Receptors.
Palanichamy K; Joshi A; Mehmetoglu-Gurbuz T; Bravo MF; Shlain MA; Schiro F; Naeem Y; Garg H; Braunschweig AB
J Med Chem; 2019 Apr; 62(8):4110-4119. PubMed ID: 30925051
[TBL] [Abstract][Full Text] [Related]
44. Future and Perspectives of the Zika Virus: Drug Repurposing as a Powerful Tool for Treatment Insights.
Rampini D; Prieto DC; Colzi AL; de Araújo RV; Giarolla J
Mini Rev Med Chem; 2020; 20(18):1917-1928. PubMed ID: 32651967
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors.
Wang Y; Zhou R; Quan Y; Chen S; Shi X; Li Y; Cen S
Bioorg Med Chem Lett; 2020 Feb; 30(4):126906. PubMed ID: 31902708
[TBL] [Abstract][Full Text] [Related]
46. Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.
Kim SY; Koetzner CA; Payne AF; Nierode GJ; Yu Y; Wang R; Barr E; Dordick JS; Kramer LD; Zhang F; Linhardt RJ
Biochemistry; 2019 Feb; 58(8):1155-1166. PubMed ID: 30698412
[TBL] [Abstract][Full Text] [Related]
47. In-Depth Characterization of Zika Virus Inhibitors Using Cell-Based Electrical Impedance.
Oeyen M; Meyen E; Doijen J; Schols D
Microbiol Spectr; 2022 Aug; 10(4):e0049122. PubMed ID: 35862960
[TBL] [Abstract][Full Text] [Related]
48. Suppression of Zika Virus Infection in the Brain by the Antiretroviral Drug Rilpivirine.
Sariyer IK; Gordon J; Burdo TH; Wollebo HS; Gianti E; Donadoni M; Bellizzi A; Cicalese S; Loomis R; Robinson JA; Carnevale V; Steiner J; Ozdener MH; Miller AD; Amini S; Klein ML; Khalili K
Mol Ther; 2019 Dec; 27(12):2067-2079. PubMed ID: 31653397
[TBL] [Abstract][Full Text] [Related]
49. Comparative Analysis of African and Asian Lineage-Derived Zika Virus Strains Reveals Differences in Activation of and Sensitivity to Antiviral Innate Immunity.
Esser-Nobis K; Aarreberg LD; Roby JA; Fairgrieve MR; Green R; Gale M
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019057
[TBL] [Abstract][Full Text] [Related]
50. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
51. Zika Virus Inhibitors Based on a 1,3-Disubstituted 1
Jung E; Soto-Acosta R; Geraghty RJ; Chen L
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144841
[TBL] [Abstract][Full Text] [Related]
52. Antiviral activity of glycyrrhizic acid conjugates with amino acid esters against Zika virus.
Baltina LA; Hour MJ; Liu YC; Chang YS; Huang SH; Lai HC; Kondratenko RM; Petrova SF; Yunusov MS; Lin CW
Virus Res; 2021 Mar; 294():198290. PubMed ID: 33388394
[TBL] [Abstract][Full Text] [Related]
53. Xanthenedione (and intermediates involved in their synthesis) inhibit Zika virus migration to the central nervous system in murine neonatal models.
Poly da Silva ÍE; Lopes da Silva M; Dias RS; Santos EG; Brangioni de Paula MC; Silva de Oliveira A; Costa da Silveira Oliveira AF; Marques de Oliveira F; Canedo da Silva C; Teixeira RR; Oliveira de Paula S
Microbes Infect; 2020 Oct; 22(9):489-499. PubMed ID: 32353601
[TBL] [Abstract][Full Text] [Related]
54. In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis.
Cirne-Santos CC; de Souza Barros C; de Oliveira MC; Rabelo VW; Azevedo RC; Teixeira VL; Ferreira DF; de Palmer Paixão ICN
Sci Rep; 2020 May; 10(1):8263. PubMed ID: 32427940
[TBL] [Abstract][Full Text] [Related]
55. The A-Z of Zika drug discovery.
Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
[TBL] [Abstract][Full Text] [Related]
56. Antiviral Potential of Fucoxanthin, an Edible Carotenoid Purified from
Kang N; Kim EA; Park A; Heo SY; Heo JH; Heo SJ
Mar Drugs; 2024 May; 22(6):. PubMed ID: 38921558
[TBL] [Abstract][Full Text] [Related]
57. Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides.
Cifuentes Kottkamp A; De Jesus E; Grande R; Brown JA; Jacobs AR; Lim JK; Stapleford KA
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894466
[TBL] [Abstract][Full Text] [Related]
58. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
Pires de Mello CP; Tao X; Kim TH; Vicchiarelli M; Bulitta JB; Kaushik A; Brown AN
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967017
[TBL] [Abstract][Full Text] [Related]
59. Anti-zika virus activity of polyoxometalates.
Francese R; Civra A; Rittà M; Donalisio M; Argenziano M; Cavalli R; Mougharbel AS; Kortz U; Lembo D
Antiviral Res; 2019 Mar; 163():29-33. PubMed ID: 30653996
[TBL] [Abstract][Full Text] [Related]
60. Drug Repurposing: New Treatments for Zika Virus Infection?
Cheng F; Murray JL; Rubin DH
Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
